Moneycontrol PRO

business

USFDA scans Cipla's Indore plant over norms violations

As per USFDA guidelines, Form 483 notifies a company's management of objectionable conditions following inspection of manufacturing plant or units.

first published: Oct 20, 2015 07:10 pm

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347